Tundra Space

Tundra Space

Clinical Research Directory

Browse clinical research sites, groups, and studies.

Back to Studies
ACTIVE NOT RECRUITING
NCT02910531
PHASE2

Lipoic Acid Supplement for Cystine Stone

Sponsor: Thomas Chi, MD

View on ClinicalTrials.gov

Summary

This study evaluates how daily alpha lipoic acid supplementation affects cystine kidney stone recurrence. Half of the subjects will receive 1200 mg alpha lipoic acid orally daily for three years, while the other half will receive a placebo. The funding source for this clinical trial is FDA OOPD.

Official title: The Effect of Lipoic Acid Natural Supplement on Cystine Stone Formation

Key Details

Gender

All

Age Range

18 Years - Any

Study Type

INTERVENTIONAL

Enrollment

50

Start Date

2017-06-19

Completion Date

2025-06

Last Updated

2023-12-20

Healthy Volunteers

No

Conditions

Interventions

DIETARY_SUPPLEMENT

Alpha lipoic acid

Already mentioned in arm/group descriptions.

DRUG

Placebo

Already mentioned in arm/group descriptions.

Locations (1)

University of California, San Francisco

San Francisco, California, United States